The new report by Expert Market Research titled, ‘Global Giant Cell Arteritis Treatment Market Size, Share, Growth, Report and Forecast 2023-2028’, gives an in-depth analysis of the global giant cell arteritis treatment market, assessing the market based on its segments like treatment type, end use, and major regions.
The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Request a free sample copy in PDF or view the report summary@ https://www.expertmarketresearch.com/reports/giant-cell-arteritis-treatment-market/requestsample
The key highlights of the report include:
Market Overview (2018-2028)
- Forecast CAGR (2023-2028): 5.1%
The rising prevalence of giant cell arteritis is driving the demand for the giant cell arteritis treatment market. This condition is more common amongst the geriatric population.
The market growth is propelled by growing health consciousness and improving living conditions in developing countries. In the healthcare sector, governments around the world are spending vast sums in research and development activities. It is expected that the ensuing technical advances and innovations in the healthcare sector would provide a catalyst for business growth. Further, increasing disposable incomes, combined with the growing ageing population, are contributing factors for the growth of the market in the forecast period.
Industry Definition and Major Segments
Giant cell arteritis (GCA), also called as temporal arteritis, is an inflammatory disease in large blood vessels, usually around the brain and head. Symptoms of GCA may include pain in the temples, flu, headache, double vision, and difficulty in opening the mouth. However, the causes of the disease are yet unknown.
Explore the full report with the table of contents@ https://www.expertmarketresearch.com/reports/giant-cell-arteritis-treatment-market
Based on the treatment type, the market is broadly classified into:
- Corticosteroid Therapy
- Others (Monoclonal Antibody)
By end-use, the market can be categorised into:
- Hospitals
- Clinics
- ASC’s
- Others
The regional markets for giant cell arteritis treatment include:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Market Trends
North America shares a significant portion in the global market for giant cell arteritis treatment. This can be attributed to the rising incidences of the disease among the patients and advance healthcare sector. Europe is also a key market for giant cell arteritis treatment owing to its high standard of living and growing health awareness of the population. Meanwhile, the Asia Pacific market is projected to have a rapid growth due to increasing developments and technological advancements in the healthcare industry in countries such as India and China.
Key Market Players
The major players in the market are F. Hoffmann-La Roche Ltd., Kiniksa Pharmaceuticals, Ltd., Teva Pharmaceutical Industries Ltd., and Tianjin Tianyao Pharmaceutical Co., Ltd., among others.
The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
About Us:
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Media Contact:
Company Name: Claight Corporation
Contact Person:- Adam Lee, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
